A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease
Condition(s):Chronic Kidney Disease; AnemiaLast Updated:May 18, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Kidney Disease; AnemiaLast Updated:May 18, 2011Completed
Condition(s):Chronic Kidney Disease (CKD)Last Updated:June 15, 2017Completed
Condition(s):Chronic Kidney Disease stage3Last Updated:July 14, 2021Recruiting
Condition(s):Chronic Kidney Disease stage4Last Updated:June 20, 2019Completed
Condition(s):Mesenchymal Stem Cells; Diabetic NephropathyLast Updated:April 21, 2021Recruiting
Condition(s):Chronic Kidney Diseases; Physical Activity; Exercise TherapyLast Updated:February 27, 2020Completed
Condition(s):Chronic Kidney DiseaseLast Updated:May 12, 2021Active, not recruiting
Condition(s):Chronic Kidney DiseasesLast Updated:September 1, 2020Completed
Condition(s):Chronic Kidney Disease Due to Hypertension; Chronic Kidney Disease Due to Type 2 Diabetes MellitusLast Updated:April 28, 2020Completed
Condition(s):Polycystic Kidney DiseaseLast Updated:March 2, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.